A 45-year-old woman was evaluated in the rheumatology clinic because of possible IgG4-related disease. She had polyclonal ...

The National Cancer Center Japan (NCC ... of such mouse models could significantly accelerate the nation’s drug development. The NCC has a collection of patient-derived xenograft (PDX) mouse ...

This research has the potential to give an entirely new perspective on the role of the immune system in cancer progression ...

A 75-year-old woman with rheumatoid arthritis and multiple myeloma was admitted to the hospital with abdominal pain. She had ...

“Nobody is more invested in your success than the patient you are looking at,” said Denise Cutlip, who has lung cancer and is involved in reviewing grant development. “We need you to succeed ...

A model similar to ChatGPT can identify cancer, recommend treatment options, and forecast survival rates for various types of ...

In their paper, the team concluded, “Accurate, robust, and rapid pathology sample assessment provided by CHIEF will contribute to the development of personalized cancer management.” ...

As any treatment for thyroid cancer kills thyroid cells, the thyroid will not be able to make enough thyroid hormone following treatment. This can lead to the development of hypothyroidism.

A medication that is currently used for chronic kidney disease in patients with ... head of research and development at Bayer’s Pharmaceuticals Division, said the company is “eager to ...

Algeria has been approved for membership in the BRICS New Development Bank (NDB), the country’s finance ministry has announced. The decision was taken on Saturday and announced by NDB chief ...

A common drug used to treat kidney cancer could slash the risk of heart attacks, a study suggests. Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced ...